Opportunistic infections complicating immunotherapy for non‐small cell lung cancer

Immunotherapy has produced durable responses in numerous advanced and metastatic cancers, especially advanced non‐small cell lung carcinoma (NSCLC). However, opportunistic infection has become a major risk for patients who have received immune checkpoint inhibitors (ICIs). Early diagnosis of infecti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Main Authors: Liu, Ziwei, Liu, Tao, Zhang, Xiaotong, Si, Xiaoyan, Wang, Hanping, Zhang, Jingjia, Huang, Hui, Sun, Xuefeng, Wang, Jinglan, Wang, Mengzhao, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Brief Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262884/
https://ncbi.nlm.nih.gov/pubmed/32311221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13422
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares